With a team of over 400 employees, B·R·A·H·M·S utilizes its own patented biomarkers to create advanced diagnostic insights for patients and medical professionals. Their products, which are leaders in specialized markets, are distributed to customers in more than 65 countries worldwide. The company's primary focus lies in the research, development, and production of diagnostic tests that target biomarkers, specifically for sepsis, bacterial infections, cardiovascular disease, and neurological disorders. By leveraging their expertise in biotechnology, B·R·A·H·M·S aims to improve patient outcomes and provide superior diagnostic solutions.